United StatesOxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, packaged by IntegraDose Compounding Services LLC (NDC 71139-0012-1), lot 20250620OXY-1, expiration 10/18/2025 — 853 500 mL bags distributed nationwide in the United States — are affected. Testing revealed there was no oxytocin in the IV bag (subpotent drug), and the recall is ongoing.
What's being recalled
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
Recalling firm: IntegraDose Compounding Services LLC, Minneapolis, MN, United States.
How to identify it
Lot #: 20250620OXY-1, Expiration date 10/18/2025
The hazard
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)